Regulation of natural killer cell activity

Current Opinion in Immunology

Volumn 19, Issue 1, 2007, Pages 46-54

  Kirwan, Sheryl E ^a   Burshtyn, Deborah N ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; BACTERIUM; CELL ACTIVITY; CELL INTERACTION; CELL MATURATION; CELL MEMBRANE POTENTIAL; CYTOKINE RELEASE; DENDRITIC CELL; FUNCTIONAL STATUS; HUMAN; LYMPH NODE; MEMORY; NATURAL KILLER CELL; NONHUMAN; PARASITE; REVIEW; SIGNAL TRANSDUCTION; VIRUS;

ANIMALS; HUMANS; KILLER CELLS, NATURAL; SIGNAL TRANSDUCTION;

EID: 33846086979     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.11.012     Document Type: Review

References (74)

1. Rajagopalan S., and Long E.O. Understanding how combinations of HLA and KIR genes influence disease. J Exp Med 201 (2005) 1025-1029
2. Lodoen M.B., and Lanier L.L. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18 (2006) 391-398
3. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
4. Parham P. Immunogenetics of killer cell immunoglobulin-like receptors. Mol Immunol 42 (2005) 459-462
5. Kane K.P., Lavender K.J., and Ma B.J. Ly-49 receptors and their functions. Crit Rev Immunol 24 (2004) 321-348
6. Vidal S.M., and Lanier L.L. NK cell recognition of mouse cytomegalovirus-infected cells. Curr Top Microbiol Immunol 298 (2006) 183-206
7. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 3 (2003) 781-790
8. Gasser S., Orsulic S., Brown E.J., and Raulet D.H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436 (2005) 1186-1190. This article provides insight into how expression of activating ligands can be induced.
9. Ogasawara K., Benjamin J., Takaki R., Phillips J.H., and Lanier L.L. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 6 (2005) 938-945
10. Graham D.B., Cella M., Giurisato E., Fujikawa K., Miletic A.V., Kloeppel T., Brim K., Takai T., Shaw A.S., Colonna M., et al. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J Immunol 177 (2006) 2349-2355
11. Upshaw J.L., Arneson L.N., Schoon R.A., Dick C.J., Billadeau D.D., and Leibson P.J. NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat Immunol 7 (2006) 524-532
12. Cella M., Fujikawa K., Tassi I., Kim S., Latinis K., Nishi S., Yokoyama W., Colonna M., and Swat W. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J Exp Med 200 (2004) 817-823
13. •] use PLCγ2-knockout mice to show the requirement of PLCγ2 in all forms of natural cytotoxicity.
14. •].
15. Ljutic B., Carlyle J.R., Filipp D., Nakagawa R., Julius M., and Zuniga-Pflucker J.C. Functional requirements for signaling through the stimulatory and inhibitory mouse NKR-P1 (CD161) NK cell receptors. J Immunol 174 (2005) 4789-4796
16. Chiesa S., Mingueneau M., Fuseri N., Malissen B., Raulet D.H., Malissen M., Vivier E., and Tomasello E. Multiplicity and plasticity of natural killer cell signaling pathways. Blood 107 (2006) 2364-2372
17. Huntington N.D., Xu Y., Nutt S.L., and Tarlinton D.M. A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells. J Exp Med 201 (2005) 1421-1433
18. Hesslein D.G., Takaki R., Hermiston M.L., Weiss A., and Lanier L.L. Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci USA 103 (2006) 7012-7017
19. Mason L.H., Willette-Brown J., Taylor L.S., and McVicar D.W. Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. J Immunol 176 (2006) 6615-6623
20. Rajagopalan S., Bryceson Y.T., Kuppusamy S.P., Geraghty D.E., van der Meer A., Joosten I., and Long E.O. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4 (2006) e9
21. + NKT cells regulated by the Src kinase Fgr. Blood 107 (2006) 3647-3655
22. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
23. Bryceson Y.T., March M.E., Barber D.F., Ljunggren H.G., and Long E.O. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med 202 (2005) 1001-1012
24. Kopcow H.D., Allan D.S., Chen X., Rybalov B., Andzelm M.M., Ge B., and Strominger J.L. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 102 (2005) 15563-15568
25. Kirwan S.E., and Burshtyn D.N. Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1). J Immunol 175 (2005) 5006-5015
26. Treanor B., Lanigan P.M., Kumar S., Dunsby C., Munro I., Auksorius E., Culley F.J., Purbhoo M.A., Phillips D., Neil M.A., et al. Microclusters of inhibitory killer immunoglobulin-like receptor signaling at natural killer cell immunological synapses. J Cell Biol 174 (2006) 153-161
27. Roncagalli R., Taylor J.E., Zhang S., Shi X., Chen R., Cruz-Munoz M.E., Yin L., Latour S., and Veillette A. Negative regulation of natural killer cell function by EAT-2, a SAP-related adaptor. Nat Immunol 6 (2005) 1002-1010
28. Di Santo J.P. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol 24 (2006) 257-286. This is an excellent review of NK development.
29. Woll P.S., Martin C.H., Miller J.S., and Kaufman D.S. Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 175 (2005) 5095-5103
30. Grzywacz B., Kataria N., Sikora M., Oostendorp R.A., Dzierzak E.A., Blazar B.R., Miller J.S., and Verneris M.R. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood (2006) 10.1182/blood-2006-04-020198
31. Wang J.W., Howson J.M., Ghansah T., Desponts C., Ninos J.M., May S.L., Nguyen K.H., Toyama-Sorimachi N., and Kerr W.G. Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295 (2002) 2094-2097
32. Lowin-Kropf B., Kunz B., Schneider P., and Held W. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors. Eur J Immunol 32 (2002) 773-782
33. ••] provide evidence that the MHC class I-specific receptor interaction with ligand influences the functional state of NK cells.
34. ••]
35. ••].
36. Roth C., Carlyle J.R., Takizawa H., and Raulet D.H. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. Immunity 13 (2000) 143-153
37. Carlyle J.R., Jamieson A.M., Gasser S., Clingan C.S., Arase H., and Raulet D.H. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci USA 101 (2004) 3527-3532
38. Grundemann C., Bauer M., Schweier O., von Oppen N., Lassing U., Saudan P., Becker K.F., Karp K., Hanke T., Bachmann M.F., et al. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 176 (2006) 1311-1315
39. Ito M., Maruyama T., Saito N., Koganei S., Yamamoto K., and Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 203 (2006) 289-295
40. Iizuka K., Naidenko O.V., Plougastel B.F., Fremont D.H., and Yokoyama W.M. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 4 (2003) 801-807
41. Lee K.M., McNerney M.E., Stepp S.E., Mathew P.A., Schatzle J.D., Bennett M., and Kumar V. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 199 (2004) 1245-1254
42. Eissmann P., and Watzl C. Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. J Immunol 177 (2006) 3170-3177
43. Tassi I., and Colonna M. The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cγ signaling pathways in human NK cells. J Immunol 175 (2005) 7996-8002
44. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., Carson W.E., and Caligiuri M.A. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 97 (2001) 3146-3151
45. Freud A.G., Yokohama A., Becknell B., Lee M.T., Mao H.C., Ferketich A.K., and Caligiuri M.A. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 203 (2006) 1033-1043
46. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 101 (2003) 3052-3057
47. Ferlazzo G., Thomas D., Lin S.L., Goodman K., Morandi B., Muller W.A., Moretta A., and Munz C. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 172 (2004) 1455-1462
48. H1-type response within the lymph nodes.
49. Hayakawa Y., and Smyth M.J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176 (2006) 1517-1524. This article demonstrates the distinction of two mature mouse NK cell subsets based on the expression of CD27.
50. ••] describe a newly defined chimeric cell, termed the IKDC, which expresses both NK- and DC-associated markers and shares many their classical functions, including cytolysis, cytokine production and antigen presentation.
51. ••].
52. ••].
53. Chaudhry U.I., Katz S.C., Kingham T.P., Pillarisetty V.G., Raab J.R., Shah A.B., and DeMatteo R.P. In vivo overexpression of Flt3 ligand expands and activates murine spleen natural killer dendritic cells. FASEB J 20 (2006) 982-984
54. Raulet D.H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 5 (2004) 996-1002
55. Yokoyama W.M., Kim S., and French A.R. The dynamic life of natural killer cells. Annu Rev Immunol 22 (2004) 405-429
56. dim natural killer cell subsets. J Immunol 161 (1998) 400-408
57. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 166 (2001) 6477-6482
58. Robertson M.J. Role of chemokines in the biology of natural killer cells. J Leukoc Biol 71 (2002) 173-183
59. Lira S.A. A passport into the lymph node. Nat Immunol 6 (2005) 866-868
60. Bajenoff M., Breart B., Huang A.Y., Qi H., Cazareth J., Braud V.M., Germain R.N., and Glaichenhaus N. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 203 (2006) 619-631. In this article, the authors report the first dynamic intravital imaging of NK cells in LNs.
61. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., and Sallusto F. Induced recruitment of NK cells to lymph nodes provides IFN-γ for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
62. Wald O., Weiss I.D., Wald H., Shoham H., Bar-Shavit Y., Beider K., Galun E., Weiss L., Flaishon L., Shachar I., et al. IFN-γ acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 176 (2006) 4716-4729
63. Salazar-Mather T.P., Orange J.S., and Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1α)-dependent pathways. J Exp Med 187 (1998) 1-14
64. Salazar-Mather T.P., Lewis C.A., and Biron C.A. Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver. J Clin Invest 110 (2002) 321-330
65. Gazit R., Gruda R., Elboim M., Arnon T.I., Katz G., Achdout H., Hanna J., Qimron U., Landau G., Greenbaum E., et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7 (2006) 517-523. This study shows the critical importance of NK migration into the lung and of natural cytotoxicity receptor 1 in the elimination of influenza virus after infection.
66. Reading P.C., Whitney P.G., Barr D.P., Smyth M.J., and Brooks A.G. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur J Immunol 36 (2006) 897-905
67. -/- mice restored their natural resistance to T. gondii.
68. Kottilil S., Shin K., Planta M., McLaughlin M., Hallahan C.W., Ghany M., Chun T.W., Sneller M.C., and Fauci A.S. Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. J Infect Dis 189 (2004) 1193-1198
69. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 20 (2006) 896-905
70. Infante-Duarte C., Weber A., Kratzschmar J., Prozorovski T., Pikol S., Hamann I., Bellmann-Strobl J., Aktas O., Dorr J., Wuerfel J., et al. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J 19 (2005) 1902-1904
71. Zhang X., Wei H., Wang H., and Tian Z. Involvement of interaction between Fractalkine and CX3CR1 in cytotoxicity of natural killer cells against tumor cells. Oncol Rep 15 (2006) 485-488
72. bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA 103 (2006) 5941-5946
73. + subset of NK cells that had slightly expanded. The responses were highly dependent on LFA-1, P/E-selectin and NKG2D.
74. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107 (2006) 3624-3631